Cargando…
Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review
BACKGROUND: Merkel cell carcinoma is a rare and aggressive neoplasm originating from mechanoreceptor Merkel cells of the stratum basale of the epidermis. Cases affecting the vulva are exceedingly rare, with the currently available literature primarily in case report form. BODY: Systematic review of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264489/ https://www.ncbi.nlm.nih.gov/pubmed/28138393 http://dx.doi.org/10.1186/s40661-017-0037-x |
_version_ | 1782500115628425216 |
---|---|
author | Nguyen, Austin Huy Tahseen, Ahmed I. Vaudreuil, Adam M. Caponetti, Gabriel C. Huerter, Christopher J. |
author_facet | Nguyen, Austin Huy Tahseen, Ahmed I. Vaudreuil, Adam M. Caponetti, Gabriel C. Huerter, Christopher J. |
author_sort | Nguyen, Austin Huy |
collection | PubMed |
description | BACKGROUND: Merkel cell carcinoma is a rare and aggressive neoplasm originating from mechanoreceptor Merkel cells of the stratum basale of the epidermis. Cases affecting the vulva are exceedingly rare, with the currently available literature primarily in case report form. BODY: Systematic review of the PubMed database returned 17 cases of Merkel cell carcinoma affecting the vulva. Patients presented at a mean age of 59.6 years with a firm, mobile vulvar mass. Symptoms of pain, erythema, pruritus, edema, and ulceration have been reported. Tumor histology is consistent with that of neuroendocrine tumors and typical Merkel cell carcinomas. Neuroendocrine and cytokeratin immunostains are frequently utilized in histopathological workup. Surgical management was the unanimous first-line therapy with adjuvant radiation in most cases. Recurrence occurred in 70.6% of patients at a mean follow-up of 6.3 months. Mortality was at 47.0% at a mean of 7.8 months after initial operation. CONCLUSION: Merkel cell carcinoma affecting the vulva is an extremely rare and highly aggressive neoplasm. The present review of published cases serves to comprehensively describe the clinical course and treatment approaches for vulvar Merkel cell carcinoma. |
format | Online Article Text |
id | pubmed-5264489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52644892017-01-30 Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review Nguyen, Austin Huy Tahseen, Ahmed I. Vaudreuil, Adam M. Caponetti, Gabriel C. Huerter, Christopher J. Gynecol Oncol Res Pract Review BACKGROUND: Merkel cell carcinoma is a rare and aggressive neoplasm originating from mechanoreceptor Merkel cells of the stratum basale of the epidermis. Cases affecting the vulva are exceedingly rare, with the currently available literature primarily in case report form. BODY: Systematic review of the PubMed database returned 17 cases of Merkel cell carcinoma affecting the vulva. Patients presented at a mean age of 59.6 years with a firm, mobile vulvar mass. Symptoms of pain, erythema, pruritus, edema, and ulceration have been reported. Tumor histology is consistent with that of neuroendocrine tumors and typical Merkel cell carcinomas. Neuroendocrine and cytokeratin immunostains are frequently utilized in histopathological workup. Surgical management was the unanimous first-line therapy with adjuvant radiation in most cases. Recurrence occurred in 70.6% of patients at a mean follow-up of 6.3 months. Mortality was at 47.0% at a mean of 7.8 months after initial operation. CONCLUSION: Merkel cell carcinoma affecting the vulva is an extremely rare and highly aggressive neoplasm. The present review of published cases serves to comprehensively describe the clinical course and treatment approaches for vulvar Merkel cell carcinoma. BioMed Central 2017-01-25 /pmc/articles/PMC5264489/ /pubmed/28138393 http://dx.doi.org/10.1186/s40661-017-0037-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Nguyen, Austin Huy Tahseen, Ahmed I. Vaudreuil, Adam M. Caponetti, Gabriel C. Huerter, Christopher J. Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review |
title | Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review |
title_full | Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review |
title_fullStr | Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review |
title_full_unstemmed | Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review |
title_short | Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review |
title_sort | clinical features and treatment of vulvar merkel cell carcinoma: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264489/ https://www.ncbi.nlm.nih.gov/pubmed/28138393 http://dx.doi.org/10.1186/s40661-017-0037-x |
work_keys_str_mv | AT nguyenaustinhuy clinicalfeaturesandtreatmentofvulvarmerkelcellcarcinomaasystematicreview AT tahseenahmedi clinicalfeaturesandtreatmentofvulvarmerkelcellcarcinomaasystematicreview AT vaudreuiladamm clinicalfeaturesandtreatmentofvulvarmerkelcellcarcinomaasystematicreview AT caponettigabrielc clinicalfeaturesandtreatmentofvulvarmerkelcellcarcinomaasystematicreview AT huerterchristopherj clinicalfeaturesandtreatmentofvulvarmerkelcellcarcinomaasystematicreview |